[Therapeutic trial with fucidin in systemic scleroderma].
The signs and symptoms in systemic sclerosis were improved by systemic therapy with fucidine. In patients with untreated systemic sclerosis, asparaginic acid and glutaminic acid were increased in blood serum and asparagine and glutamine decreased. These compounds with fucidine therapy normalized.
D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D005672:Fusidic Acid / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000097:blood / Q000188:drug therapy*; D013997:Time Factors
D000596:Amino Acids; D005672:Fusidic Acid
Therapieversuch mit Fucidin bei systemischer Sklerodermie.